| Recombinant activated factor VII as treatment for uncontrolled mucosal haemorrhage. | |
| | |
MedLine Citation:
|
PMID: 22693200 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
We report the use of a haemostatic drug (recombinant activated factor VII (rFVIIa)) in a patient who presented a slow but constant bleed in oesophageal mucosa (which required frequent red blood cell transfusion) due to ingestion of caustic products. The administration of rFVIIa ceased bleeding and allowed mucosal cicatrisation and patient haemodynamic stabilisation and clinical recovery. |
| | |
Authors:
|
J Gracia; I Prieto |
Publication Detail:
|
Type: Journal Article Date: 2011-06-29 |
Journal Detail:
|
Title: BMJ case reports Volume: 2011 ISSN: 1757-790X ISO Abbreviation: BMJ Case Rep Publication Date: 2011 |
Date Detail:
|
Created Date: 2012-06-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101526291 Medline TA: BMJ Case Rep Country: England |
Other Details:
|
Languages: eng Pagination: - Citation Subset: IM |
Affiliation:
|
Department of ICU, Ramon y Cajal Hospital, Madrid, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Atypical rabies with MRI findings: clue to the diagnosis.
Next Document: Giant melanoma of the scalp - discussion of a rare clinical presentation.